1. Home
  2. WIX vs LGND Comparison

WIX vs LGND Comparison

Compare WIX & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wix.com Ltd.

WIX

Wix.com Ltd.

HOLD

Current Price

$80.79

Market Cap

4.4B

Sector

Technology

ML Signal

HOLD

Logo Ligand Pharmaceuticals Incorporated

LGND

Ligand Pharmaceuticals Incorporated

HOLD

Current Price

$204.65

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WIX
LGND
Founded
2006
1987
Country
Israel
United States
Employees
N/A
68
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
3.7B
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
WIX
LGND
Price
$80.79
$204.65
Analyst Decision
Buy
Strong Buy
Analyst Count
23
7
Target Price
$143.05
$245.86
AVG Volume (30 Days)
2.7M
194.8K
Earning Date
05-20-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$15.80
$1.50
Revenue Next Year
$13.21
$18.28
P/E Ratio
$28.86
$76.27
Revenue Growth
N/A
N/A
52 Week Low
$60.22
$97.48
52 Week High
$190.92
$227.92

Technical Indicators

Market Signals
Indicator
WIX
LGND
Relative Strength Index (RSI) 42.09 53.79
Support Level $75.00 $194.45
Resistance Level $94.72 $207.72
Average True Range (ATR) 3.22 8.46
MACD -1.13 -0.49
Stochastic Oscillator 10.53 63.62

Price Performance

Historical Comparison
WIX
LGND

About WIX Wix.com Ltd.

Wix.com is a software-as-a-service content management system platform that allows users to create, customize, and manage websites for themselves, or for clients. Wix is best known for its Wix Editor service for self-creators, but in recent years has invested heavily and introduced its Wix Studio offering for partners, who are agencies and developers. Wix also offers a range of business solutions such as payment services and marketing products.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: